
Bausch + Lomb Corporation: shareholders and insiders
Price
$20.95
November 18, 2026Market cap $7.4B
What Ploutos Investor adds for Bausch + Lomb
Part of Ploutos Investor, €9.99 a month
- The full history: 6 fiscal years, from 2020
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Insiders and their shares
Purchases and sales by officers and directors from Nov 19, 2025 to Nov 2, 2026, from their own Form 4 filings.
Bought on the market
$1.2M
9 people
Sold on the market
$3.5M
2 people
From Nov 19, 2025 to Nov 19, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan0%
- The rest100%
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 19, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·bought $1.2M by 9 people·sold $3.5M by 2 people
- 2025: no buys, no sales
- 2026: bought $1.2M by 9 people, sold $3.5M by 2 people
- Oct 29, 2026Frederick MunschSVP, Controller and CAOKind
- Oct 29, 2026Frederick MunschSVP, Controller and CAOKind
- Oct 29, 2026Frederick MunschSVP, Controller and CAOKind
- Oct 29, 2026Russel C RobertsonDirectorKind
- Oct 29, 2026John PaulsonDirectorKind
- Oct 29, 2026Eduardo AlfonsoDirectorKind
- Aug 12, 2026Barbara TrebbiDirectorKind
- Aug 12, 2026Laurence E PaulDirectorKind
- Aug 12, 2026Robert J ChersiDirectorKind
- Aug 10, 2026Frederick MunschSVP, Controller and CAOKind
- Aug 7, 2026Eschenbach Andrew C. VonDirectorKind
- Aug 6, 2026Eschenbach Andrew C. VonDirectorKind
- Aug 5, 2026Andrew J. StewartPresident, GPICKind
- Aug 5, 2026Frederick MunschSVP, Controller and CAOKind
- Aug 5, 2026Yehia HashadEVP of R&D and CMOKind
- Aug 5, 2026Sam EldessoukyEVP and CFOKind
- Aug 5, 2026Luc BonnefoyPresident, SurgicalKind
- Aug 5, 2026A Robert D BaileyEVP & Chief Legal OfficerKind
- Aug 5, 2026Brent L SaundersChairman of the Board and CEOKind
- Aug 5, 2026Brent L SaundersChairman of the Board and CEOKind
- Jun 12, 2026Luc BonnefoyPresident, SurgicalKind
- May 26, 2026Eschenbach Andrew C. VonDirectorKind
- May 26, 2026Thomas W. Ross Sr.DirectorKind
- May 26, 2026Russel C RobertsonDirectorKind
- May 26, 2026John PaulsonDirectorKind
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 29, 2026 | Frederick MunschSVP, Controller and CAO | 24.1K | $17.96 | $432.9K | Form 4 | |
| Oct 29, 2026 | Frederick MunschSVP, Controller and CAO | 87.9K | $18.00 | $1.6M | Form 4 | |
| Oct 29, 2026 | Frederick MunschSVP, Controller and CAO | 112.0K | $20.48 | $2.3M | Form 4 | |
| Oct 29, 2026 | Russel C RobertsonDirector | 1,256 | $20.40 | $25.6K | Form 4 | |
| Oct 29, 2026 | John PaulsonDirector | 1,125 | $20.40 | $23.0K | Form 4 | |
| Oct 29, 2026 | Eduardo AlfonsoDirector | 1,125 | $20.40 | $23.0K | Form 4 | |
| Aug 12, 2026 | Barbara TrebbiDirector | 11.8K | – | – | Form 4 | |
| Aug 12, 2026 | Laurence E PaulDirector | 11.8K | – | – | Form 4 | |
| Aug 12, 2026 | Robert J ChersiDirector | 11.8K | – | – | Form 4 | |
| Aug 10, 2026 | Frederick MunschSVP, Controller and CAO | 52.9K | $16.78 | $887.7K | Form 4 | |
| Aug 7, 2026 | Eschenbach Andrew C. VonDirector | 6,059 | $16.58 | $100.5K | Form 4 | |
| Aug 6, 2026 | Eschenbach Andrew C. VonDirector | 12.5K | $16.50 | $206.3K | Form 4 | |
| Aug 5, 2026 | Andrew J. StewartPresident, GPIC | 16.8K | – | – | Form 4 | |
| Aug 5, 2026 | Frederick MunschSVP, Controller and CAO | 9,091 | – | – | Form 4 | |
| Aug 5, 2026 | Yehia HashadEVP of R&D and CMO | 21.0K | – | – | Form 4 | |
| Aug 5, 2026 | Sam EldessoukyEVP and CFO | 50.3K | – | – | Form 4 | |
| Aug 5, 2026 | Luc BonnefoyPresident, Surgical | 16.8K | – | – | Form 4 | |
| Aug 5, 2026 | A Robert D BaileyEVP & Chief Legal Officer | 33.6K | – | – | Form 4 | |
| Aug 5, 2026 | Brent L SaundersChairman of the Board and CEO | 4,231 | $16.76 | $70.9K | Form 4 | |
| Aug 5, 2026 | Brent L SaundersChairman of the Board and CEO | 281.9K | – | – | Form 4 | |
| Jun 12, 2026 | Luc BonnefoyPresident, Surgical | 1,008 | $15.08 | $15.2K | Form 4 | |
| May 26, 2026 | Eschenbach Andrew C. VonDirector | 15.8K | $15.78 | $250.0K | Form 4 | |
| May 26, 2026 | Thomas W. Ross Sr.Director | 15.8K | $15.78 | $250.0K | Form 4 | |
| May 26, 2026 | Russel C RobertsonDirector | 15.8K | $15.78 | $250.0K | Form 4 | |
| May 26, 2026 | John PaulsonDirector | 15.8K | $15.78 | $250.0K | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before May 26, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by BLCO's officers and directors from 2022 up to November 18, 2025, 4 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
No filing over 5%
Since Dec 18, 2024 nobody has filed a Schedule 13D or 13G for Bausch + Lomb shares.
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Oaktree (Marks)In the quarter+1.7%
- Glenview CapitalIn the quarter-2.0%
- Icahn (Carl C)In the quarter-32%
- D.E. ShawIn the quarter+1.7%
- Third Point (Loeb)In the quarter
- Point72 (Cohen)In the quarter+49%
- Citadel Advisors (Griffin)In the quarter+2.1%
- Millennium Mgmt (Englander)In the quarter-71%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Oaktree (Marks) | 3.44M | +1.7% | $57M | 1.07% |
| Glenview Capital | 1.88M | -2.0% | $32M | 0.57% |
| Icahn (Carl C) | 2.38M | -32% | $40M | 0.43% |
| D.E. Shaw | 3.38M | +1.7% | $58M | 0.04% |
| Third Point (Loeb) | 85.0K | $1.4M | 0.03% | |
| Point72 (Cohen) | 261.4K | +49% | $4.4M | 0.01% |
| Citadel Advisors (Griffin) | 1.01M | +2.1% | $17M | 0.01% |
| Millennium Mgmt (Englander) | 50.7K | -71% | $900.0K | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 0.72% of its shares outstanding were held short, -14.0% since the report before.
- Shares held short
- 2.54M
- 0.72%
- Since the report before2.96M on Sep 30, 2026
- -14.0%
- 3.6
- 705.4K
- More days to cover thanof 4,578 US-listed companies with enough volume
- 43%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 3.49M
- Nov 15, 2023: Shares held short 3.84M
- Nov 30, 2023: Shares held short 3.44M
- Dec 15, 2023: Shares held short 2.50M
- Dec 29, 2023: Shares held short 2.11M
- Jan 12, 2024: Shares held short 1.96M
- Jan 31, 2024: Shares held short 2.28M
- Feb 15, 2024: Shares held short 2.06M
- Feb 29, 2024: Shares held short 1.54M
- Mar 15, 2024: Shares held short 1.23M
- Mar 28, 2024: Shares held short 1.50M
- Apr 15, 2024: Shares held short 1.63M
- Apr 30, 2024: Shares held short 1.78M
- May 15, 2024: Shares held short 1.88M
- May 31, 2024: Shares held short 2.07M
- Jun 14, 2024: Shares held short 2.15M
- Jun 28, 2024: Shares held short 2.25M
- Jul 15, 2024: Shares held short 2.06M
- Jul 31, 2024: Shares held short 1.68M
- Aug 15, 2024: Shares held short 1.91M
- Aug 30, 2024: Shares held short 2.21M
- Sep 13, 2024: Shares held short 2.20M
- Sep 30, 2024: Shares held short 1.44M
- Oct 15, 2024: Shares held short 1.52M
- Oct 31, 2024: Shares held short 1.12M
- Nov 15, 2024: Shares held short 967.3K
- Nov 29, 2024: Shares held short 1.08M
- Dec 13, 2024: Shares held short 1.21M
- Dec 31, 2024: Shares held short 1.22M
- Jan 15, 2025: Shares held short 1.26M
- Jan 31, 2025: Shares held short 1.73M
- Feb 14, 2025: Shares held short 1.22M
- Feb 28, 2025: Shares held short 1.86M
- Mar 14, 2025: Shares held short 2.04M
- Mar 31, 2025: Shares held short 1.98M
- Apr 15, 2025: Shares held short 2.01M
- Apr 30, 2025: Shares held short 1.87M
- May 15, 2025: Shares held short 2.58M
- May 30, 2025: Shares held short 2.54M
- Jun 13, 2025: Shares held short 2.62M
- Jun 30, 2025: Shares held short 3.36M
- Jul 15, 2025: Shares held short 4.12M
- Jul 31, 2025: Shares held short 4.06M
- Aug 15, 2025: Shares held short 3.70M
- Aug 29, 2025: Shares held short 3.23M
- Sep 15, 2025: Shares held short 3.22M
- Sep 30, 2025: Shares held short 3.16M
- Oct 15, 2025: Shares held short 3.39M
- Oct 31, 2025: Shares held short 3.49M
- Nov 14, 2025: Shares held short 3.22M
- Nov 28, 2025: Shares held short 3.26M
- Dec 15, 2025: Shares held short 3.15M
- Dec 31, 2025: Shares held short 3.20M
- Jan 15, 2026: Shares held short 3.68M
- Jan 30, 2026: Shares held short 3.36M
- Feb 13, 2026: Shares held short 3.16M
- Feb 27, 2026: Shares held short 2.66M
- Mar 13, 2026: Shares held short 4.01M
- Mar 31, 2026: Shares held short 3.61M
- Apr 15, 2026: Shares held short 3.71M
- Apr 30, 2026: Shares held short 3.61M
- May 15, 2026: Shares held short 2.50M
- May 29, 2026: Shares held short 4.06M
- Jun 15, 2026: Shares held short 4.40M
- Jun 30, 2026: Shares held short 3.99M
- Jul 15, 2026: Shares held short 3.80M
- Jul 31, 2026: Shares held short 3.03M
- Aug 14, 2026: Shares held short 3.18M
- Aug 31, 2026: Shares held short 3.41M
- Sep 15, 2026: Shares held short 3.16M
- Sep 30, 2026: Shares held short 2.96M
- Oct 15, 2026: Shares held short 2.54M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading27.6% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 27.6% of the shares in the reported trades were short sales, against 26.9% in the 14 before.
- Last 14 sessionsOct 30, 2026 – Nov 18, 2026
- 27.6%
- The 14 beforeOct 12, 2026 – Oct 29, 2026
- 26.9%
- Change
- +0.7 pts
- Short sales a dayon average, of 362.6K shares
- 100.2K
- More than atof 3,656 US-listed companies, same days
- 3%
- Median of alleight in ten from 34.4% to 63.7%
- 50.3%
- Short sales
- Oct 12, 2026: Short sales 33.8%
- Oct 13, 2026: Short sales 35.5%
- Oct 14, 2026: Short sales 44.6%
- Oct 15, 2026: Short sales 33.4%
- Oct 16, 2026: Short sales 57%
- Oct 19, 2026: Short sales 50.4%
- Oct 20, 2026: Short sales 29.1%
- Oct 21, 2026: Short sales 30.3%
- Oct 22, 2026: Short sales 47.5%
- Oct 23, 2026: Short sales 53.8%
- Oct 26, 2026: Short sales 60.8%
- Oct 27, 2026: Short sales 66%
- Oct 28, 2026: Short sales 15.4%
- Oct 29, 2026: Short sales 9.4%
- Oct 30, 2026: Short sales 15.2%
- Nov 2, 2026: Short sales 37.4%
- Nov 3, 2026: Short sales 13.1%
- Nov 4, 2026: Short sales 19.2%
- Nov 5, 2026: Short sales 31.2%
- Nov 6, 2026: Short sales 32.5%
- Nov 9, 2026: Short sales 26.9%
- Nov 10, 2026: Short sales 26.5%
- Nov 11, 2026: Short sales 18.9%
- Nov 12, 2026: Short sales 25.8%
- Nov 13, 2026: Short sales 43.8%
- Nov 16, 2026: Short sales 30.5%
- Nov 17, 2026: Short sales 43.4%
- Nov 18, 2026: Short sales 38.4%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Brent L SaundersCEO and Chairman of the BoardDirectly1.26M
- Sam EldessoukyEVP and CFODirectly393.5K
- A Robert D BaileyEVP & Chief Legal OfficerDirectly264.2K
- Yehia HashadEVP of R&D and CMODirectly187.4K
- Luc BonnefoyPresident, SurgicalDirectly103.8K
- Andrew J. StewartPresident, GPICDirectly103.2K
- Russel C RobertsonDirectorDirectly95.5K
- John PaulsonDirectorDirectly90.9K
- Nathalie D. BernierDirectorDirectly85.5K
- Thomas W. Ross Sr.DirectorDirectly85.2K
- Sarah B KavanaghDirectorDirectly69.5K
- Eschenbach Andrew C. VonDirectorDirectly63.7K
- Karen LingDirectorDirectly61.5K
- Frederick MunschSVP, Controller and CAODirectly45.8K
- Steven H CollisDirectorDirectly42.0K
- Eduardo AlfonsoDirectorDirectly32.2K
- Barbara TrebbiDirectorDirectly11.8K
- Laurence E PaulDirectorDirectly11.8K
- Robert J ChersiDirectorDirectly11.8K
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Brent L SaundersCEO and Chairman of the Board | 1.26M | – | Aug 5, 2026 | Form 4 |
| Sam EldessoukyEVP and CFO | 393.5K | – | Aug 5, 2026 | Form 4 |
| A Robert D BaileyEVP & Chief Legal Officer | 264.2K | – | Aug 5, 2026 | Form 4 |
| Yehia HashadEVP of R&D and CMO | 187.4K | – | Aug 5, 2026 | Form 4 |
| Luc BonnefoyPresident, Surgical | 103.8K | – | Aug 5, 2026 | Form 4 |
| Andrew J. StewartPresident, GPIC | 103.2K | – | Aug 5, 2026 | Form 4 |
| Russel C RobertsonDirector | 95.5K | – | Oct 29, 2026 | Form 4 |
| John PaulsonDirector | 90.9K | – | Oct 29, 2026 | Form 4 |
| Nathalie D. BernierDirector | 85.5K | – | May 26, 2026 | Form 4 |
| Thomas W. Ross Sr.Director | 85.2K | – | May 26, 2026 | Form 4 |
| Sarah B KavanaghDirector | 69.5K | – | May 26, 2026 | Form 4 |
| Eschenbach Andrew C. VonDirector | 63.7K | – | Aug 7, 2026 | Form 4 |
| Karen LingDirector | 61.5K | – | May 26, 2026 | Form 4 |
| Frederick MunschSVP, Controller and CAO | 45.8K | – | Oct 29, 2026 | Form 4 |
| Steven H CollisDirector | 42.0K | – | May 26, 2026 | Form 4 |
| Eduardo AlfonsoDirector | 32.2K | – | Oct 29, 2026 | Form 4 |
| Barbara TrebbiDirector | 11.8K | – | Aug 12, 2026 | Form 4 |
| Laurence E PaulDirector | 11.8K | – | Aug 12, 2026 | Form 4 |
| Robert J ChersiDirector | 11.8K | – | Aug 12, 2026 | Form 4 |
A lower bound: it counts only the 19 officers and directors with a market trade since Nov 20, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- DFAXDimensional World ex. U.S. Core Equity 2 ETFWeight in the fund0.00%
- DFICDimensional International Core Equity 2 ETFWeight in the fund0.00%
| ETF | Weight in the fund | Holdings as of |
|---|---|---|
| DFAXDimensional World ex. U.S. Core Equity 2 ETF | 0.00% | Jul 31, 2026 |
| DFICDimensional International Core Equity 2 ETF | 0.00% | Jul 31, 2026 |
2 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 93
- Q4 2025: Managers 99
- Q1 2026: Managers 96
- Q2 2026: Managers 98
Institutional investors by quarter
The fund managers holding BLCO, quarter by quarter, from Q2 2022 to Q2 2025, 13 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 98 managers held 38.18M shares, worth $632M. During the quarter 19 opened a position, 17 closed one, 31 added and 30 trimmed.
The largest holders, Q2 2026
- Icahn (Carl C)In the quarter
- Oaktree (Marks)In the quarter+1.7%
- Deutsche Bank Ag\In the quarter-3.0%
- D.E. ShawIn the quarter+5.5%
- Davidson Kempner Capital ManagementIn the quarter+44%
- Goldentree Asset ManagementIn the quarter
- Price T Rowe AssociatesIn the quarter+76%
- Caspian CapitalIn the quarter
- Glenview CapitalIn the quarter+0.4%
- Arrowstreet Capital, Limited PartnershipIn the quarter+39%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| Icahn (Carl C) | 3.50M | $58M | |
| Oaktree (Marks) | 3.44M | +1.7% | $57M |
| Deutsche Bank Ag\ | 3.42M | -3.0% | $57M |
| D.E. Shaw | 3.32M | +5.5% | $55M |
| Davidson Kempner Capital Management | 3.16M | +44% | $52M |
| Goldentree Asset Management | 2.66M | $44M | |
| Price T Rowe Associates | 2.16M | +76% | $36M |
| Caspian Capital | 2.00M | $33M | |
| Glenview Capital | 1.92M | +0.4% | $32M |
| Arrowstreet Capital, Limited Partnership | 1.36M | +39% | $23M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Bausch + Lomb's filings show?
Who buys and sells is one part of Bausch + Lomb's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have BLCO's insiders bought or sold?
From May 26, 2026 to Nov 2, 2026 Bausch + Lomb's insiders bought 0 and sold $3.5M of shares on the market. 0% of the sales were under set 10b5-1 plans.
Which well-known managers hold BLCO?
8 of the managers we track held the shares on Sep 30, 2026. The largest position was D.E. Shaw's, worth $58M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.